Spinal Technologies, LLC v. Mazor Robotics INC.

CourtDistrict Court, W.D. New York
DecidedAugust 30, 2022
Docket1:21-cv-00883
StatusUnknown

This text of Spinal Technologies, LLC v. Mazor Robotics INC. (Spinal Technologies, LLC v. Mazor Robotics INC.) is published on Counsel Stack Legal Research, covering District Court, W.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Spinal Technologies, LLC v. Mazor Robotics INC., (W.D.N.Y. 2022).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF NEW YORK

SPINAL TECHNOLOGIES, LLC, Plaintiff, v. DECISION AND ORDER 21-CV-883S MAZOR ROBOTICS INC., MAZOR ROBOTICS LTD., Defendants.

I. Introduction In this removed diversity products liability action, Plaintiff alleges that Defendants breached their contract, breached warranties, and were unjustly enriched from defects in their device, the Mazor X. Plaintiff seeks damages, indemnification, and declaratory relief. (Docket No. 1, Ex. A, Compl.; Docket No. 1, Notice of Removal ¶ 1.) Plaintiff Spinal Technologies is a Texas limited liability company (Docket No. 1, Ex. A, Compl. ¶ 2; Docket No. 1, Notice of Removal ¶ 8). Spinal Technologies is a managing entity of a medical practice, Spine Associates, engaged in the practice orthopedic spinal surgery (Docket No. 1, Ex. A, Compl. ¶ 3). Defendant Mazor Robotics Inc. (“Mazor”) is a Delaware corporation with its principal place of business is Minnesota and Defendant Mazor Robotics Ltd. (“MRL”) is an Israeli corporation with its principal place of business in Israel (Docket No. 1, Notice of Removal ¶¶ 9, 10; Docket No. 1, Ex. A, Compl. ¶¶ 4, 5). Mazor develops, manufactures, and sells surgical guidance systems for spinal and brain surgery (Docket No. 1, Ex. A, Compl. ¶ 6). Before this Court is Defendants’ Motion to Dismiss (Docket No. 5). For the reasons stated below, this Motion is granted and this case is dismissed. II. Background A. Facts as Alleged in the Complaint

Plaintiff alleges that it used Mazor’s surgical guidance equipment and software, Mazor’s Robotics Renaissance, since 2011 (Docket No. 1, Ex. A, Compl. ¶ 9). Mazor’s Renaissance device is a very small robot that is placed over the patient. Using computer software with computed tomography (CT) and x-ray scans, the surgeon can see the patient’s spine and use the robot to align a drill to accurately place pedicle screws during spinal surgery. (Id. ¶ 10.) In 2016, Chris Sells, a Mazor executive, introduced Plaintiff to Mazor’s new surgical guidance system, the Mazor X (id. ¶ 11). Sells represented to Plaintiff that Mazor X was more accurate and would diminish risk and provide better protection than the Renaissance, allowing real time navigation during procedures (id. ¶¶ 12, 13). Based

on representations by Defendant and demonstration of the device, Plaintiff expressed interest in purchasing the Mazor X (id. ¶ 15; see id. ¶ 14). The Mazor X, however, would not be available until 2017, so Defendant offered to sell to Plaintiff a new Renaissance device that could be exchanged for a Mazor X once the new device became available (id. ¶¶ 16, 18). On December 6, 2016, Plaintiff entered into a sales agreement with Defendant to purchase a Renaissance device with the understanding that it could be traded-in for an available Mazor X (id. ¶ 19, Ex. A, Trade-In Program Agreement (“Sales Agreement”)). This Sales Agreement contained a warranty that the Renaissance was free of defects in materials and workmanship (id. ¶ 24, Ex. A, Sales Agreement § 6.1.2 (the “Disclaimer”)). This warranty and the terms of the Sales Agreement also applied to a traded Mazor X (id. ¶ 25; see Docket No. 5, Defs. Memo. at 9 n.2). Plaintiff then entered into a Master Lease Agreement with De Lage Landen

Financial Services (“DLL”) for lease of the new Renaissance (Docket No. 1, Ex. A, Compl. ¶¶ 22, 23, Ex. B, DLL Master Lease). Plaintiff contends that it would not have agreed to this Master Lease (or the sales agreement) but for the representations about the speed and safety of the Mazor X (id. ¶ 45). Defendants deny liability because Plaintiff never directly purchased the Mazor X from them due to the Master Lease Agreement. Further, Defendants assert that they were not parties to the Master Lease. (Docket No. 5, Defs. Memo. at 7 n.1.) Defendant delivered and installed the new Renaissance machine at the end of 2016 and then replaced it with the Mazor X device on or about January 9, 2017 (Docket No. 1, Ex. A, Compl. ¶¶ 26, 27). Plaintiff complains that the Mazor X failed to function as

warranted, consistently malfunctioning from the first day of installation (id. ¶¶ 29, 30). This caused a “enormous” problem because a surgeon cannot see the nerves or the spinal cord and the Mazor X was designed to aid the surgeon in ensuring that pedicle screws are accurately placed in specific spots (id. ¶¶ 31, 32). Defendant’s representatives were present during surgeries using Mazor X and each time the device malfunctioned, Defendant internally noted the service call (id. ¶¶ 33-37, Ex. C). Plaintiff argues either that it never accepted the Mazor X due to its performance issues (id. ¶ 38) or that (if it deemed to have accepted the device) that this acceptance was revoked (id. ¶ 67). The Food and Drug Administration later issued a recall for the Mazor X related to the device design but Defendants failed to notify Plaintiff of the recall (id. ¶¶ 39, 40). Plaintiff, instead, had to continue using its older (at least five-year-old) Renaissance machine (id. ¶ 42). Despite the continued malfunction of the Mazor X, Plaintiff made lease payments

to DLL, paying a total of $426,232.67 toward the purchase of Mazor X (id. ¶ 41). But on April 2019, Plaintiff ceased making lease payments on the Mazor X (id. ¶ 43). On or about August 2019, DLL sued Plaintiff for the unpaid lease (id. ¶ 44). Plaintiff alleges in the First Cause of Action breach of the express warranty that the machines would be free from defects (id. ¶¶ 47-51). The Second Cause of Action alleges breach of implied warranty (id. ¶¶ 53-58). The Third Cause of Action alleges breach of contract (id. ¶¶ 60-69). Alternatively, the Fourth Cause of Action alleges unjust enrichment and quantum meruit (id. ¶¶ 71-74). In the Fifth Cause of Action, Plaintiff seeks a declaratory judgment that it rejected the Mazor X or revoked acceptance of the device (id. ¶¶ 76-80). The Sixth Cause of Action alleges common law indemnification and/or

contribution if Plaintiff is found liable to DLL (id. ¶¶ 82-83). Plaintiff seeks to recover $426,232.67 for damages in each of the First, Second, Third, and Fourth Causes of Action (the same amount as the lease payment total); an Order declaring Plaintiff’s rejection or revoked acceptance of the Mazor X in the Fifth Cause of Action; and in the Sixth Cause of Action Defendants’ defense and indemnification of Plaintiff from DLL’s lawsuit (id., WHEREFORE Cl.). B. Proceedings Plaintiff filed its suit in New York Supreme Court, Erie County (Docket No. 1, Ex. B). Defendants removed this action to this Court (Docket No. 1). Meanwhile, Plaintiff settled DLL’s claims against it for breach of the Master Lease Agreement in Texas (Docket No. 5, Defs. Atty. Decl. ¶ 4, Ex. 2; Docket No. 9, Pl. Memo. at 5). C. Motion to Dismiss (Docket No. 5) Defendants moved to dismiss (Docket No. 51) arguing that Mazor performed its

obligations under the sales agreement (Docket No. 5, Defs. Memo. at 16-18). Defendants point out that the agreement expressly disclaimed implied warranties (id. at 18-19). Next, Defendants argue that Plaintiff’s breach of contract and settlement of the DLL’s lawsuit preclude indemnification claim and contribution was not available for this contract action (id. at 20-22, 22). Finally, Defendants assert Plaintiff accepted delivery of the Mazor X and never revoked its acceptance (id. at 22-24). Within its response to this Motion, Plaintiff stipulates to dismissal of MRL as a Defendant (Docket No. 9, Pl. Memo. at 8). Responses were due by August 31, 2021, and reply by September 7, 2021 (Docket

No. 8). After timely submissions (Docket Nos. 9, 10), the Motion is deemed submitted without oral argument. III. Discussion A. Preliminary Matters—Claims against Defendant MRL Defendants moved to dismiss claims against Israeli corporation MRL on personal jurisdiction grounds (Docket No. 5, Defs. Memo.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Erie Railroad v. Tompkins
304 U.S. 64 (Supreme Court, 1938)
Klaxon Co. v. Stentor Electric Manufacturing Co.
313 U.S. 487 (Supreme Court, 1941)
Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Wilton v. Seven Falls Co.
515 U.S. 277 (Supreme Court, 1995)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
MedImmune, Inc. v. Genentech, Inc.
549 U.S. 118 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Maltz v. Union Carbide Chemicals & Plastics Co.
992 F. Supp. 286 (S.D. New York, 1998)
Hicks v. Association of American Medical Colleges
503 F. Supp. 2d 48 (District of Columbia, 2007)
Knight v. HE Yerkes and Associates, Inc.
675 F. Supp. 139 (S.D. New York, 1987)
In Re Crazy Eddie Securities Litigation
802 F. Supp. 804 (E.D. New York, 1992)
Leon v. Martinez
638 N.E.2d 511 (New York Court of Appeals, 1994)
McCarthy v. Turner Construction, Inc.
953 N.E.2d 794 (New York Court of Appeals, 2011)
Matter of Allstate Ins. Co.(stolarz-Njm)
81 N.Y.2d 219 (New York Court of Appeals, 1993)
Brown & Lowe Co. v. Potolski
221 A.D. 299 (Appellate Division of the Supreme Court of New York, 1927)
Mandarin Trading Ltd. v. Wildenstein
944 N.E.2d 1104 (New York Court of Appeals, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Spinal Technologies, LLC v. Mazor Robotics INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/spinal-technologies-llc-v-mazor-robotics-inc-nywd-2022.